Amerise Biosciences Intrinsic Value
AMERISE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹1.52 | ₹1.37 - ₹1.67 | +149.2% | Book Value/Share: ₹7.14, P/B: 1.0x |
Want to compare with current market value? Check AMERISE share price latest .
Valuation Comparison Chart
AMERISE Intrinsic Value Analysis
What is the intrinsic value of AMERISE?
Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Amerise Biosciences (AMERISE) is ₹1.52 (median value). With the current market price of ₹0.61, this represents a +149.2% variance from our estimated fair value.
The valuation range spans from ₹1.52 to ₹1.52, indicating ₹1.52 - ₹1.52.
Is AMERISE undervalued or overvalued?
Based on our multi-method analysis, Amerise Biosciences (AMERISE) appears to be trading below calculated value by approximately 149.2%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 1.80 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
Related Pages for Amerise Biosciences
Additional stock information and data for AMERISE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹3 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |